The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Pictured Above / Moussa Youdim Professor Emeritus Moussa Youdim from the Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology is the recipient of the 2022 Israel Prize for Life Sciences in recognition of his pioneering, groundbreaking scientific achievements in the field of neuropharmacology. The committee noted that Prof. Youdim, “… has placed generations of undergraduates and graduates, many of whom hold key positions, in Israeli academia and in the biotechnology industry. His publications have received wide international acclaim and have won him many awards.” Technion President Professor Uri Sivan said, “It is my honor to congratulate…
Two Technion faculty members have won Proof of Concept (PoC) grants from the European Commission for Research (ERC). The prestigious grants, each worth $165,000, are intended to promote the application and commercialization of academic research, including the establishment of a start-up company. They are awarded only to researchers who have won an ERC grant in the past. Professor Shulamit Levenberg from the Faculty of Biomedical Engineering won an award for her innovative development for 3D bioprinting and post-printing tissue growth: Print and Grow. Three-dimensional (3D) bioprinting is one of the most promising technologies in the world for tissue engineering. Bioprinting…
When astronaut Eytan Stibbe takes off into space at the end of March, he will take with him a copy of the Nano Bible, developed at the Technion. This unique technological item was lent to him by the Israel Museum in Jerusalem, where it is currently on display in the Shrine of the Book alongside the Dead Sea Scrolls. The Nano Bible is the most innovative and smallest copy of the Bible that exists. Technion scientists engraved the 1.2 million letters of the Bible on a gold-plated layer of silicon (on a surface the size of a grain of sugar)…
The Technion’s Social Hub and the Center for the Promotion of Learning and Teaching have teamed up with the NGO Wikimedia to encourage students to write Hebrew Wikipedia articles, with the aim of sharing knowledge with the public and expanding the free knowledge in the fields of science and engineering. Hebrew Wikipedia is the fifth largest site in Israel in terms of views, with about 2,000 page views per minute. Today, there are more than 300,000 entries on the Hebrew Wikipedia site, but there is a shortage of quality and quantity when it comes to STEM subjects — science, technology,…
Three research groups have won a unique grant from the Technion’s Human Health Initiative (THHI). The brainchild of Technion President Professor Uri Sivan, the TTHI promotes interdisciplinary research related to the worlds of health and medicine. “Human health is one of the main challenges facing humanity in the 21st century,” said President Sivan. “Like other huge challenges, a significant revolution in human health requires multidisciplinary efforts. The THHI brings together researchers from different faculties on the premise that removing boundaries between faculties and disciplines is essential to preserve the Technion’s world-class status and to meet the challenges of the 21st…
Pictured Above / Prof. Emeritus Joshua Zak (left), Prof. Emeritus Yoram Palti (right) Israel’s Minister of Education, Dr. Yifat Shasha-Biton, recently announced that two Technion faculty members have been recognized with prestigious Israel Prizes for their contributions to their field and society. Professor Emeritus Yoram Palti of the Technion’s Rappaport Faculty of Medicine is the winner of this year’s Israel Prize for Entrepreneurship and Technological Innovation, and Professor Emeritus Joshua Zak of the Department of Physics has been awarded the 2022 Israel Prize for Physics and Chemistry Research. Prof. Palti was given the honor for a non-invasive, highly selective method…
Antibiotics are a double-edged sword: on the one hand, antibiotics are essential to curing bacterial infections. On the other hand, their use promotes proliferation of antibiotic-resistant bacteria. Using genomic sequencing techniques and machine learning analysis of patient records, researchers from the Technion – Israel institute of Technology and Maccabi KSM Research and Innovation Center have developed an antibiotic-prescribing algorithm that cuts the risk of emergence of antibiotic resistance by half. The paper, published in Science, is a collaboration between the research group of Professor Roy Kishony from the Technion Faculty of Biology and the Henry and Marilyn Taub Faculty of…
Pictured Above / Professor Reut Shalgi Researchers at the Technion’s Rappaport Faculty of Medicine have discovered that the body has the capability of curing various neurodegenerative diseases, including Huntington’s, Alzheimer’s, and ALS. Unfortunately, however, the body often fails to detect the problem and activate the solution. Professor Reut Shalgi likened the situation to computer troubleshooting. Often you don’t recognize at first that something is wrong with your computer. And when you do, finding the solution is hit or miss. “It is the same with our cells,” she said. “They do not always realize there is a problem, or know how…
Photo credit: Advance Materials Magazine Patients suffering from sodium-related diseases and other conditions currently must visit a clinic or hospital for blood tests that can be painful and do not provide online or immediate results. Now, Technion researchers have developed a smart, wearable “band-aid” fitted with microneedles that continuously monitor a person’s medical condition and send the data to the patient or doctor. The research, recently featured on the cover of Advanced Materials, was led by Professor Hossam Haick, postdoctoral fellow Dr. Youbin Zheng, and Ph.D. student Rawan Omar of the Wolfson Faculty of Chemical Engineering and the Russell Berrie…
Pictured Above / Dr. Kira Radinksy / Photo credit: Omer Hacohen The last step in developing a drug or medical treatment is the clinical trial, which confirms the treatment’s efficacy in humans and its safety. While a long and expensive process, a successful clinical trial is essential to receiving approval from the FDA or other regulating authorities. Yet clinical trials have long underrepresented women, leading to misdiagnosed diseases and adverse drug reactions. A new article in the Journal of the American Medical Informatics Association (JAMIA) by researchers at the Henry and Marilyn Taub Faculty of Computer Science at the Technion…
Pictured Above / Prof. Yotam Bar-On (left) and Dina Khateeb / Photo credit: Rami Shelush, Technion Spokesperson’s Office. Although the original form of the novel coronavirus — SARS-CoV-2 — was armed with an effective system against mutations, it was not immune to them. Indeed, the virus has since “split” into variants according to differing evolutionary variables in different populations. These mutations occur in the spike protein of the virus, which allows it to penetrate the cells in our body. The development of new variants is the result of random mutations and natural selection. Most mutations do not significantly alter the…
Pictured Above / Professor Marcelle Machluf, dean of the Technion Faculty of Biotechnology and Food Engineering. Israel’s food sector is a $20 billion business, representing 5% of the country’s GDP. Yet lack of capital, stagnating innovation, and rapidly changing consumer demands threaten to erode this success. The new Carasso FoodTech Innovation Center, part of the Faculty of Biotechnology and Food Engineering’s Bio-Health Technology Innovation Initiative, aims to tackle these unanswered challenges. The Center will develop sustainable ways to supply a healthy, tasty, and nutritious diet to a growing world population, while growing Israel’s food sector. “We overfish, overgrow, and overuse…